Delivery systems for antisense oligonucleotides

被引:87
作者
Garcia-Chaumont, C
Seksek, O
Grzybowska, J
Borowski, E
Bolard, J
机构
[1] Univ Paris 06, LPBC, CNRS, ESA 7033, F-75252 Paris 05, France
[2] Gdansk Univ Technol, Dept Pharmaceut Technol & Biochem, PL-80952 Gdansk, Poland
关键词
oligonucleotides; antisense; cationic lipids; liposomes; amphotericin B; gene therapy;
D O I
10.1016/S0163-7258(00)00062-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In vitro, the efficacy of the antisense approach is strongly increased by systems delivering oligodeoxyribonucleotides (ODNs) to cells. Up to now, most of the developed vectors favor ODN entrance by a mechanism based on endocytosis. Such is the case for particulate systems, including liposomes (cationic or non-cationic). cationic polyelectrolytes, and delivery systems targeted to specific receptors. Under these conditions, endosomal compartments may represent a dead end for ODNs. Current research attempts to develop conditions for escaping from these compartments. A new class of vectors acts by passive permeabilization of the plasma membrane. It includes peptides, streptolysin O, and cationic derivatives of polyene antibiotics. In vivo, the interest of a delivery system, up to now, has appeared limited. Development of vectors insensitive to the presence of serum seems to be a prerequisite for future improvements. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:255 / 277
页数:23
相关论文
共 206 条
[81]   Cell cycle-dependent distribution and specific inhibitory effect of vectorized antisense oligonucleotides in cell culture [J].
Hélin, V ;
Gottikh, M ;
Mishal, Z ;
Subra, F ;
Malvy, C ;
Lavignon, M .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (01) :95-107
[82]  
Ho PTC, 1997, SEMIN ONCOL, V24, P187
[83]   Lipitoids - novel cationic lipids for cellular delivery of plasmid DNA in vitro [J].
Huang, CY ;
Uno, T ;
Murphy, JE ;
Lee, S ;
Hamer, JD ;
Escobedo, JA ;
Cohen, FE ;
Radhakrishnan, R ;
Dwarki, V ;
Zuckermann, RN .
CHEMISTRY & BIOLOGY, 1998, 5 (06) :345-354
[84]   Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides [J].
Hughes, JA ;
Aronsohn, AI ;
Avrutskaya, AV ;
Juliano, RL .
PHARMACEUTICAL RESEARCH, 1996, 13 (03) :404-410
[85]  
Israel ZH, 1998, POLYM ADVAN TECHNOL, V9, P799, DOI 10.1002/(SICI)1099-1581(1998100)9:10/11<799::AID-PAT807>3.0.CO
[86]  
2-N
[87]  
Iversen P L, 1992, Antisense Res Dev, V2, P211
[88]   Physicochemical and morphological properties of complexes made of cationic liposomes and oligonucleotides [J].
Jääskeläinen, I ;
Sternberg, B ;
Mönkkönen, J ;
Urtti, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 167 (1-2) :191-203
[89]   OLIGONUCLEOTIDE-CATIONIC LIPOSOME INTERACTIONS - A PHYSICOCHEMICAL STUDY [J].
JAASKELAINEN, I ;
MONKKONEN, J ;
URTTI, A .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1994, 1195 (01) :115-123
[90]   Antisense pharmacodynamics: Critical issues in the transport and delivery of antisense oligonucleotides [J].
Juliano, RL ;
Alahari, S ;
Yoo, H ;
Kole, R ;
Cho, M .
PHARMACEUTICAL RESEARCH, 1999, 16 (04) :494-502